Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017247 | SCV005643989 | uncertain significance | Bardet-Biedl syndrome 2; Retinitis pigmentosa 74 | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004733821 | SCV005355272 | uncertain significance | BBS2-related disorder | 2024-05-28 | no assertion criteria provided | clinical testing | The BBS2 c.1981C>A variant is predicted to result in the amino acid substitution p.Arg661Ser. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |